magnolin has been researched along with verapamil in 1 studies
Studies (magnolin) | Trials (magnolin) | Recent Studies (post-2010) (magnolin) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
27 | 0 | 19 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cha, BY; Efferth, T; Kadioglu, O; Mitani, Y; Nakagawa, H; Nakamura, I; Satake, K; Teruya, T; Tsukamoto, M; Woo, JT; Yonezawa, T | 1 |
1 other study(ies) available for magnolin and verapamil
Article | Year |
---|---|
Epimagnolin A, a tetrahydrofurofuranoid lignan from Magnolia fargesii, reverses ABCB1-mediated drug resistance.
Topics: Adenosine Triphosphatases; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Lignans; Magnolia; Molecular Docking Simulation; Verapamil | 2018 |